Whether the FDA approves a COVID-19 booster shot or not, Pfizer and Moderna have already made their money

It's likely that millions of COVID-19 booster shots will be administered in the U.S. in the coming months, but that doesn’t mean companies like Moderna and Pfizer will report an unexpected revenue windfall this year.